Cargando…

PD-1/PD-L1 blockade, a novel strategy for targeting metastatic colorectal cancer: A systematic review and meta-analysis of randomized trials

Currently, standard treatment of patients with metastatic colorectal cancer (mCRC) comprises chemotherapy (CT) and/or biological therapy (BT) and/or best supportive care (BSC). The present study performed a meta-analysis on five phase II–III randomized clinical trials, which compared CT/BT/BSC as th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotundo, Maria Saveria, Bagnardi, Vincenzo, Rotundo, Miryam, Comandè, Mario, Zampino, Maria Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895448/
https://www.ncbi.nlm.nih.gov/pubmed/35251353
http://dx.doi.org/10.3892/ol.2022.13254